Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia

by Silvia Alonso-Lana, Marta Marquié, Marta Marquié, Agustín Ruiz, Agustín Ruiz, Mercè Boada, Mercè Boada
Published 2020-10-01

Reliable Measurements of the β-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD

by Pedro Pesini, Virginia Pérez-Grijalba, Inmaculada Monleón, Mercè Boada, Lluís Tárraga, Pablo Martínez-Lage, Itziar San-José, Manuel Sarasa
Published 2012-01-01

Clinical Applicability of the Specific Risk Score of Dementia in Type 2 Diabetes in the Identification of Patients with Early Cognitive Impairment: Results of the MOPEAD Study in S...

by Angel Michael Ortiz Zuñiga, Rafael Simó, Octavio Rodriguez-Gómez, Cristina Hernández, Adrian Rodrigo, Laura Jamilis, Laura Campo, Montserrat Alegret, Merce Boada, Andreea Ciudin
Published 2020-08-01

Correction: Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years Old

by Montserrat Alegret, Ana Espinosa, Sergi Valero, Georgina Vinyes-Junqué, Agustín Ruiz, Isabel Hernández, Maitee Rosende-Roca, Ana Mauleón, James T. Becker, Lluís Tárraga, Mercè Boada
Published 2014-01-01

Correction: Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years Old.

by Montserrat Alegret, Ana Espinosa, Sergi Valero, Georgina Vinyes-Junqué, Agustín Ruiz, Isabel Hernández, Maitee Rosende-Roca, Ana Mauleón, James T. Becker, Lluís Tárraga, Mercè Boada
Published 2014-01-01

Cut-off scores of a brief neuropsychological battery (NBACE) for Spanish individual adults older than 44 years old.

by Montserrat Alegret, Ana Espinosa, Ana Espinosa, Sergi Valero, Georgina Vinyes-Junqué, Agustín Ruiz, Isabel Hernández, Maitee Rosende-Roca, Ana Mauleón, James T Becker, Lluís Tárraga, Mercè Boada
Published 2013-01-01

Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease

by Dolores Siedlecki-Wullich, Judit Català-Solsona, Cristina Fábregas, Isabel Hernández, Jordi Clarimon, Alberto Lleó, Merce Boada, Carlos A. Saura, José Rodríguez-Álvarez, Alfredo J. Miñano-Molina
Published 2019-05-01

Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges

by Amanda Cano, Patric Turowski, Miren Ettcheto, Jason Thomas Duskey, Giovanni Tosi, Elena Sánchez-López, Maria Luisa García, Antonio Camins, Eliana B. Souto, Agustín Ruiz, Marta Marquié, Mercè Boada
Published 2021-04-01

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers

by Pascual Sánchez-Juan, Pascual Sánchez-Juan, Sonia Moreno, Sonia Moreno, Itziar de Rojas, Itziar de Rojas, Isabel Hernández, Isabel Hernández, Sergi Valero, Sergi Valero, Montse Alegret, Montse Alegret, Laura Montrreal, Pablo García González, Pablo García González, Carmen Lage, Carmen Lage, Sara López-García, Sara López-García, Eloy Rodrííguez-Rodríguez, Eloy Rodrííguez-Rodríguez, Adelina Orellana, Lluís Tárraga, Lluís Tárraga, Mercè Boada, Mercè Boada, Agustín Ruiz, Agustín Ruiz
Published 2019-12-01

Personality Factors and Subjective Cognitive Decline: The FACEHBI Cohort

by Nathalia Muñoz, Montserrat Gomà-i-Freixanet, Sergi Valero, Octavio Rodríguez-Gómez, Angela Sanabria, Alba Pérez-Cordón, Isabel Hernández, Marta Marquié, Iolao Mir, Elvira Martín, Alba Benaque, Agustín Ruiz, Lluís Tarraga, Mercè Boada, Montserrat Alegret, on behalf of the FACEHBI study
Published 2020-01-01

Correction: Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis o...

by Agustín Ruiz, Pedro Pesini, Ana Espinosa, Virginia Pérez-Grijalba, Sergi Valero, Oscar Sotolongo-Grau, Montserrat Alegret, Inmaculada Monleón, Asunción Lafuente, Mar Buendía, Marta Ibarria, Susana Ruiz, Isabel Hernández, Itziar San José, Lluís Tárraga, Mercè Boada, Manuel Sarasa
Published 2014-01-01

Correction: Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis o...

by Agustín Ruiz, Pedro Pesini, Ana Espinosa, Virginia Pérez-Grijalba, Sergi Valero, Oscar Sotolongo-Grau, Montserrat Alegret, Inmaculada Monleón, Asunción Lafuente, Mar Buendía, Marta Ibarria, Susana Ruiz, Isabel Hernández, Itziar San José, Lluís Tárraga, Mercè Boada, Manuel Sarasa
Published 2014-01-01

Blood amyloid beta levels in healthy, mild cognitive impairment and Alzheimer's disease individuals: replication of diastolic blood pressure correlations and analysis of critical c...

by Agustín Ruiz, Pedro Pesini, Ana Espinosa, Virginia Pérez-Grijalba, Sergi Valero, Oscar Sotolongo-Grau, Montserrat Alegret, Inmaculada Monleón, Asunción Lafuente, Mar Buendía, Marta Ibarria, Susana Ruiz, Isabel Hernández, Itziar San José, Lluís Tárraga, Mercè Boada, Manuel Sarasa
Published 2013-01-01

The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies

by Carla Abdelnour, Daniel Ferreira, Ketil Oppedal, Lena Cavallin, Olivier Bousiges, Lars Olof Wahlund, Jakub Hort, Zuzana Nedelska, Alessandro Padovani, Andrea Pilotto, Laura Bonanni, Milica G. Kramberger, Mercè Boada, Eric Westman, Javier Pagonabarraga, Jaime Kulisevsky, Frédéric Blanc, Dag Aarsland
Published 2020-01-01

Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease

by Shahzad Ahmad, Adelina Orellana, Isabelle Kohler, Lutz Frölich, Itziar de Rojas, Silvia Gil, Mercè Boada, Isabel Hernández, Lucrezia Hausner, Margot H. M. Bakker, Alfredo Cabrera-Socorro, Najaf Amin, Alfredo Ramírez, Agustín Ruiz, Thomas Hankemeier, Cornelia M. Van Duijn
Published 2020-10-01

Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study

by Maarten Timmers, Johannes Rolf Streffer, Alberto Russu, Yushin Tominaga, Hiroko Shimizu, Ayako Shiraishi, Kanaka Tatikola, Pascale Smekens, Anne Börjesson-Hanson, Niels Andreasen, Jorge Matias-Guiu, Miquel Baquero, Mercè Boada, Ina Tesseur, Luc Tritsmans, Luc Van Nueten, Sebastiaan Engelborghs
Published 2018-08-01

Activation of PKR causes amyloid ß-peptide accumulation via de-repression of BACE1 expression.

by Gerard Ill-Raga, Ernest Palomer, Matthew A Wozniak, Eva Ramos-Fernández, Mònica Bosch-Morató, Marta Tajes, Francesc X Guix, José J Galán, Jordi Clarimón, Carmen Antúnez, Luis M Real, Mercé Boada, Ruth F Itzhaki, César Fandos, Francisco J Muñoz
Published 2011-01-01

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease

by Susanne Ostrowitzki, Robert A. Lasser, Ernest Dorflinger, Philip Scheltens, Frederik Barkhof, Tania Nikolcheva, Elizabeth Ashford, Sylvie Retout, Carsten Hofmann, Paul Delmar, Gregory Klein, Mirjana Andjelkovic, Bruno Dubois, Mercè Boada, Kaj Blennow, Luca Santarelli, Paulo Fontoura, for the SCarlet RoAD Investigators
Published 2018-09-01

A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease

by Susanne Ostrowitzki, Robert A. Lasser, Ernest Dorflinger, Philip Scheltens, Frederik Barkhof, Tania Nikolcheva, Elizabeth Ashford, Sylvie Retout, Carsten Hofmann, Paul Delmar, Gregory Klein, Mirjana Andjelkovic, Bruno Dubois, Mercè Boada, Kaj Blennow, Luca Santarelli, Paulo Fontoura, for the SCarlet RoAD Investigators
Published 2017-12-01

Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study

by Virginia Pérez-Grijalba, Javier Arbizu, Judith Romero, Elena Prieto, Pedro Pesini, Leticia Sarasa, Fernando Guillen, Inmaculada Monleón, Itziar San-José, Pablo Martínez-Lage, Josep Munuera, Isabel Hernández, Mar Buendía, Oscar Sotolongo-Grau, Montserrat Alegret, Agustín Ruiz, Lluis Tárraga, Mercè Boada, Manuel Sarasa, The AB255 Study Group
Published 2019-12-01